ELF · e.l.f. Beauty, Inc. · Stock research

Current Thesis

A fallen consumer highflyer trying to bottom, not a fresh accelerating breakout. ELF sits at $76.42 (2026-07-03), roughly half its 52-week high of $150.99 and down about 65% from its 2024 mania peak near $220. The live sub-narrative is Rhode Hailey Bieber's brand which added $113M to Q4 FY2026 net sales and carried ~34 of the 35 percentage points of headline growth. Strip Rhode out and the core e.l.f. engine is decelerating while adjusted EPS is falling. The tape into early July is a stretched countertrend bounce off the June-29 low of $69.91 into an RSI near 82, running straight at analyst targets that cluster around spot. The whole turnaround hinges on the 2026-08-05 print; everything before it is chasing a bounce inside a structural downtrend.

Bullish and bearish views on e.l.f. Beauty, Inc.

The model's bull view on e.l.f. Beauty, Inc. (ELF), in brief: Rhode is a genuine new growth engine: contributed $113M to Q4 FY2026 net sales (reported 2026-05-20), a DTC-only brand that scaled to $212M in under three years on ~10 products, now expanding into Sephora US/Canada wholesale in autumn 2026 a real TAM step-up, not a story. The bear view: Profitability is compressing, not inflecting: Q4 adjusted EPS $0.32 vs $0.78 a year earlier; adjusted EBITDA $59M vs $81M; a $49.4M GAAP loss. Both cases follow in full.

Bull Case

• Rhode is a genuine new growth engine: contributed $113M to Q4 FY2026 net sales (reported 2026-05-20), a DTC-only brand that scaled to $212M in under three years on ~10 products, now expanding into Sephora US/Canada wholesale in autumn 2026 a real TAM step-up, not a story.
• Multiple has fully reset: FY2027 guide of $3.27–3.32 EPS puts ELF near 23x forward at $76, versus the 50–80x it carried during its 2023–24 run. The premium that made it fragile is gone.
• Tariff headwind is quantified and easing: FY2026 averaged ~55% blended tariff; the 170% China spike (2026-04-09 to 2026-05-13) already rolled back; FY2027 guidance assumes 35%. Management flagged ~$50M annualized cost impact and pushed a $1 price increase across brands a known drag, improving rather than worsening.
• Share gains + margin intact: Q4 gross margin 73%, up 140bps YoY on pricing; company kept taking mass-cosmetics share through the tariff shock.
• Structural low held: bounced off the $48.82 52-week low and reclaimed $69.91→$76.42 into month-end.

Bear Case

• Profitability is compressing, not inflecting: Q4 adjusted EPS $0.32 vs $0.78 a year earlier; adjusted EBITDA $59M vs $81M; a $49.4M GAAP loss. The +35% top line masks earnings going backward.
• Organic growth is falling off a cliff: ex-Rhode, the core is a fraction of the headline, and the FY2027 guide of +12–14% is a step-down from the 20–77% growth cadence investors paid up for.
• Downtrend of lower highs: ~$220 (2024) → $150.99 (52-week high) → $76. The June rally is countertrend; there is no higher-high structure yet.
• The blended consensus target sits near $78 essentially zero upside to spot.
• China concentration unresolved: still just under 75% of production in China (down from ~100% in 2019), leaving margins hostage to every US-China tariff headline.

Setup & Price Structure

• Last $76.42 (2026-07-03), prior close $78.75; intraday range $74.32–$79.91; 52-week band $48.82–$150.99.
• ~+9% in three sessions ($69.91 on 2026-06-29 → $76.42) pushed RSI to roughly 82 a stretched, extended bounce running into the $78–$90 supply shelf where analyst targets sit, not a clean base breakout.
• The move is a mean-reversion bounce off a washed-out low, not a trend continuation; there is no confirmed higher-low sequence and the name is fighting a multi-quarter downtrend.
• Fresh entries here are buying strength into resistance a month ahead of a binary print a low-quality location for a momentum book.

Catalyst Calendar (next 30 days)

• 2026-08-05 (after close) Q1 FY2027 earnings; consensus EPS ~$0.69. The first clean read on Rhode's wholesale ramp, the 35% tariff assumption, and whether organic growth is stabilizing. This is the binary that defines the trade.
• Autumn 2026 Rhode's Sephora US/Canada rollout; watch for pre-launch/distribution announcements that could pull sentiment forward before the print.
• Ongoing US-China tariff headlines on the 55%→35% path; any re-escalation directly re-rates the margin story.

What Would Change Our Mind

• Bullish flip: a weekly close reclaiming the ~$85–90 shelf (Canaccord's target, prior breakdown zone) on Rhode wholesale confirmation would signal a genuine trend change worth pressing; alternatively, an 2026-08-05 print showing organic re-acceleration plus a FY2027 guide raise validates the turnaround.
• Bearish confirmation: loss of the late-June bounce low re-opens the $48.82 floor and confirms the countertrend read.
• Until either resolves, this is a stand-aside the narrative worth owning (Rhode) is real, but the tape, the falling EPS, and the analyst cuts say wait for a base or wait for the print, not chase RSI 82.

Correlation Notes

• Sits in consumer discretionary / mass beauty; comps ULTA, COTY, EL (Estée Lauder) for demand read-through, though none is a pure celebrity-brand analog.
• Tariff-sensitive via China sourcing trades with US-China trade headlines and US consumer-spend data more than with any secular growth theme.
• Not an AI/semis/quantum momentum name; it will not cluster with the chip-infrastructure or quantum leaders and offers no confirmation from that book. Idiosyncratic, single-name, event-driven.